Background

Nitric Oxide (NO) is a crucial signalling molecule in the body involved in various physiological processes, including vasodilation, neurotransmitter modulation, and immune system regulation. NO is also known for its ability to inhibit cancer cell proliferation and reduce inflammation. Additionally, NO plays a crucial role in wound healing and maintaining vascular homeostasis. The use of NO in therapy has been extensively studied, but the main challenge lies in effectively and safely delivering NO to target areas without causing significant systemic side effects. In this study, nano bubbles are used to provide a precise and controlled mechanism for NO delivery.

Nano bubbles are nano meter-sized particles that can be customized to deliver specific drugs or molecules directly to target cells. In the case of NO nano bubbles, this technology allows for encapsulation and controlled release of nitric oxide, which can be utilized for more precise and effective treatments. With its customizable and controllable properties, nano bubble technology offers an innovative solution for drug delivery, enhancing efficacy while minimizing side effects.

Before NO nano bubbles can be used in clinical applications, pre-clinical testing is necessary to assess safety and determine safe dosages. Pre-clinical trials involve testing on animals to evaluate acute and chronic toxicity, biocompatibility, and therapeutic efficacy. This research aims to establish the safety of using NO nano bubbles, define safe and effective dosages for clinical applications, identify potential side effects and mitigation strategies, and provide a scientific basis for further development and human clinical trials.

Highlight of the research

The novelty of this research lies in the use of nano bubble technology for nitric oxide (NO) delivery, which represents an innovative approach that has not been extensively explored. This study is the first and novel in this field, making it crucial for paving the way toward clinical application of NO nano bubbles in disease therapy. The results of this research could offer a more effective and safer alternative compared to conventional methods. By understanding safe dosages and potential side effects, this study will provide essential data for developing new therapies that are more efficient and safer, ultimately improving the quality of life for patients with various medical conditions.

Expected results

This research is expected to produce data demonstrating that NO nano bubbles are safe for use in animals. Additionally, the study aims to establish the optimal dosage for safe and effective clinical application. Identifying and understanding potential side effects, as well as strategies to mitigate them, are also expected outcomes. Information on the biocompatibility of NO nano bubbles with biological tissues, showing the absence of adverse immune reactions, would be highly valuable. The evidence of therapeutic effectiveness from these NO nano bubbles can serve as a basis for human clinical trials and the development of more efficient and safe therapies